Lowe Brockenbrough & CO Inc Novartis Ag Transaction History

Lowe Brockenbrough & CO Inc

  • $1.74 Billion
  • Q2 2025

A detailed history of Lowe Brockenbrough & CO Inc transactions in Novartis Ag stock. As of the latest transaction made, Lowe Brockenbrough & CO Inc holds 14,534 shares of NVS stock, worth $1.9 Million. This represents 0.1% of its overall portfolio holdings.

Number of Shares
14,534
Previous 14,522 0.08%
Holding current value
$1.9 Million
Previous $1.62 Million 8.65%
% of portfolio
0.1%
Previous 0.11%

Shares

32 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2025

Aug 11, 2025
BUY
$101.96 - $121.01 $1,223 - $1,452
12 Added 0.08%
14,534 $1.76 Million
Q1 2025

May 13, 2025
SELL
$97.14 - $115.57 $21,467 - $25,540
-221 Reduced 1.5%
14,522 $1.62 Million
Q4 2024

Feb 11, 2025
SELL
$96.78 - $117.18 $59,810 - $72,417
-618 Reduced 4.02%
14,743 $1.43 Million
Q3 2024

Oct 28, 2024
BUY
$106.13 - $120.89 $78,748 - $89,700
742 Added 5.08%
15,361 $1.77 Million
Q2 2024

Aug 12, 2024
SELL
$92.57 - $107.37 $50,913 - $59,053
-550 Reduced 3.63%
14,619 $1.56 Million
Q1 2024

May 15, 2024
SELL
$95.27 - $108.47 $106,797 - $121,594
-1,121 Reduced 6.88%
15,169 $1.47 Million
Q4 2023

Feb 14, 2024
BUY
$92.27 - $101.54 $31,833 - $35,031
345 Added 2.16%
16,290 $1.64 Million
Q3 2023

Nov 14, 2023
SELL
$94.73 - $105.13 $43,954 - $48,780
-464 Reduced 2.83%
15,945 $1.62 Million
Q2 2023

Aug 10, 2023
SELL
$92.52 - $104.91 $38,303 - $43,432
-414 Reduced 2.46%
16,409 $1.66 Million
Q1 2023

May 12, 2023
SELL
$80.03 - $92.81 $13,445 - $15,592
-168 Reduced 0.99%
16,823 $1.55 Million
Q4 2022

Feb 14, 2023
SELL
$75.55 - $92.52 $1,511 - $1,850
-20 Reduced 0.12%
16,991 $1.54 Million
Q3 2022

Nov 01, 2022
BUY
$74.61 - $87.26 $14,474 - $16,928
194 Added 1.15%
17,011 $1.29 Million
Q2 2022

Jul 27, 2022
SELL
$80.52 - $93.75 $140,265 - $163,312
-1,742 Reduced 9.39%
16,817 $1.42 Million
Q1 2022

May 04, 2022
SELL
$80.11 - $90.62 $103,822 - $117,443
-1,296 Reduced 6.53%
18,559 $1.63 Million
Q4 2021

Feb 14, 2022
SELL
$79.7 - $88.13 $17,852 - $19,741
-224 Reduced 1.12%
19,855 $1.74 Million
Q3 2021

Nov 15, 2021
BUY
$81.78 - $95.14 $56,591 - $65,836
692 Added 3.57%
20,079 $1.64 Million
Q2 2021

Aug 13, 2021
BUY
$85.24 - $94.15 $12,956 - $14,310
152 Added 0.79%
19,387 $1.77 Million
Q1 2021

May 14, 2021
BUY
$83.5 - $98.47 $13,109 - $15,459
157 Added 0.82%
19,235 $1.64 Million
Q4 2020

Feb 04, 2021
SELL
$78.07 - $94.43 $20,220 - $24,457
-259 Reduced 1.34%
19,078 $1.8 Million
Q3 2020

Oct 26, 2020
SELL
$82.14 - $91.0 $71,543 - $79,261
-871 Reduced 4.31%
19,337 $1.68 Million
Q2 2020

Aug 13, 2020
SELL
$80.93 - $91.1 $61,506 - $69,236
-760 Reduced 3.62%
20,208 $1.77 Million
Q1 2020

May 21, 2020
SELL
$70.67 - $99.01 $12,720 - $17,821
-180 Reduced 0.85%
20,968 $1.73 Million
Q4 2019

Jan 31, 2020
SELL
$84.35 - $95.37 $1,012 - $1,144
-12 Reduced 0.06%
21,148 $2 Million
Q3 2019

Nov 21, 2019
BUY
$85.54 - $94.26 $5,303 - $5,844
62 Added 0.29%
21,160 $1.84 Million
Q2 2019

Aug 12, 2019
SELL
$75.4 - $92.8 $377 - $464
-5 Reduced 0.02%
21,098 $1.93 Million
Q1 2019

May 21, 2019
BUY
$75.32 - $86.15 $30,805 - $35,235
409 Added 1.98%
21,103 $2.03 Million
Q4 2018

Feb 15, 2019
BUY
$73.66 - $82.02 $47,510 - $52,902
645 Added 3.22%
20,694 $1.78 Million
Q3 2018

Nov 15, 2018
SELL
$66.94 - $77.43 $11,245 - $13,008
-168 Reduced 0.83%
20,049 $1.73 Million
Q2 2018

Aug 10, 2018
SELL
$64.91 - $73.36 $25,314 - $28,610
-390 Reduced 1.89%
20,217 $1.53 Million
Q1 2018

Apr 30, 2018
BUY
$70.39 - $84.15 $19,568 - $23,393
278 Added 1.37%
20,607 $1.67 Million
Q4 2017

Jan 30, 2018
BUY
$72.33 - $77.64 $1,446 - $1,552
20 Added 0.1%
20,329 $1.71 Million
Q3 2017

Nov 07, 2017
BUY
$74.14 - $77.27 $1.51 Million - $1.57 Million
20,309
20,309 $1.74 Million

Others Institutions Holding NVS

# of Institutions
1,561
Shares Held
136M
Call Options Held
1.72M
Put Options Held
1.7M
View Full List

About NOVARTIS AG

NVS Quotes by TradingView
  • Ticker NVS
  • Exchange OTC
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,151,000,064
  • Market Cap $281B
  • Description
  • Novartis AG researches, develops, manufactures, and markets healthcare products worldwide. The company operates through two segments, Innovative Medicines and Sandoz. The Innovative Medicines segment offers prescription medicines for patients and healthcare providers. It also provides ophthalmology, neuroscience, immunology, hepatology, dermatol...
More about NVS
Track This Portfolio

Track Lowe Brockenbrough & CO Inc Portfolio

Follow Lowe Brockenbrough & CO Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Lowe Brockenbrough & CO Inc, based on Form 13F filings with the SEC.

News

Stay updated on Lowe Brockenbrough & CO Inc with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email